Systematic review of multidisciplinary teams in the management of lung cancer

Lung Cancer

Volumn 60, Issue 1, 2008, Pages 14-21

  Coory, M ^a   Gkolia, P ^b   Yang, I A ^c   Bowman, R V ^c   Fong, K M ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Epidemiol and Hlth Info Branch   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Lung cancer; Multidisciplinary; Multidisciplinary clinic; Multidisciplinary team; Patient care team; Survival; Tumour board

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUSAL ATTRIBUTION; CLINICAL TRIAL; HEALTH CARE PRACTICE; HUMAN; LUNG CANCER; MEDLINE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TEAMWORK; TELECONFERENCE; VIDEOCONFERENCING;

HUMANS; LUNG NEOPLASMS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 41149156298     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.01.008     Document Type: Review

References (41)

1. Neville A. Lung cancer. Clin Evid (2005) 1903-1920
2. National Cancer Guidance Group. Guidance on commissioning cancer services. Improving outcomes in lung cancer: the manual (1998), NHS Executive, London
3. Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with lung cancer. A national clinical guideline vol. 80 (2005), SIGN, Edinburgh p. 1-63
4. National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the prevention, diagnosis and management of lung cancer (2004), NHMRC, Canberra
5. National Institute for Clinical Excellence. Lung cancer: diagnosis and treatment of lung cancer (2005), NICE, London. http://www.nice.org.uk/pdf/CG024niceguideline.pdf
6. Department of Health. Manual for cancer services (2004), Department of Health, London
7. Fletcher J. What is heterogeneity and is it important?. BMJ 334 (2007) 94-96
8. Murray P.V., O'Brien M.E.R., Sayer R., Cooke N., Knowles A.C., Miller A.C., et al. The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. Lung cancer 42 3 (2003) 283-290
9. Price A., Kerr G., Gregor A., Ironside J., and Little F. The impact of multidisciplinary teams and site specialisation on the use of radiotherapy in elderly people with non-small cell lung cancer (NSCLC). Radiother Oncol 64 Suppl. 1 (2002) 80 [abstract]
10. Bowen E.F., Anderson J.R., and Roddie M.E. Improving surgical resection rates in lung cancer without a two stop service. Thorax 58 (2003) 368 [letter]
11. Davison A.G., Eraut C.D., Haque A.S., Doffman S., Tanqueray A., Trask C.W., et al. Telemedicine for multidisciplinary lung cancer meetings. J Telemed Telecare 10 3 (2004) 140-143
12. Martin-Ucar A.E., Waller D.A., Atkins J.L., Swinson D., O'Byrne K.J., and Peake M.D. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer. Lung Cancer 46 (2004) 227-232
13. Dillman R.O., and Chico S.D. Cancer patient survival improvement is correlated with the opening of a community cancer centre: comparisons with intramural and extramural benchmarks. J Oncol Pract 1 (2005) 84-92
14. Forrest L.M., McMillan D.C., McArdle C.S., and Dunlop D.J. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 93 (2005) 977-978
15. Seek A., and Hogle W. Modelling a better way: navigating the healthcare system for patients with lung cancer. Clin J Oncol Nurs 11 (2007) 81-85
16. Deegan P.C., Heath L., Brunskill J., Kinnear W.J., Morgan S.A., and Johnston I.D. Reducing waiting times in lung cancer. J Roy Coll Physicians Lond 32 (1998) 339-343
17. Laroche C., Wells F., Coulden R., Stewart S., Goddard M., Lowry E., et al. Improving surgical resection rate in lung cancer. Thorax 53 6 (1998) 445-449
18. Magee L.R., Laroche C.M., and Gilligan D. Clinical trials in lung cancer: evidence that a programmed investigation unit and a multidisciplinary clinic may improve recruitment. Clin Oncol 13 (2001) 310-311
19. Dedes K.J., Szucs T.D., Bodis S., Joerger M., Lowy A., Russi E.W., et al. Management and cost of treating lung cancer patients in a university hospital. Pharmacoeconomics 22 7 (2004) 435-444
20. Wong S., Rosenthal M.A., deBoer R., Green M.D., and Fox R.M. Five years managing metastatic non-small cell lung cancer: experience at a teaching hospital. Intern Med J 34 8 (2004) 458-463
21. Conron M., Phuah S., Steinfort D., Dabscheck E., Wright G., and Hart D. Analysis of multidisciplinary lung cancer practice. Intern Med J 37 (2007) 18-25
22. Free C.M., Ellis M., Beggs L., Beggs D., Morgan S.A., and Baldwin D.R. Lung cancer outcomes at a UK cancer unit between 1998-2001. Lung Cancer 57 (2007) 222-228
23. Leo F., Venissac N., Poudenx M., Otto J., Mouroux J., and Groupe d'Oncologie Thoracique Azure'en ( GOThA). Multidisciplinary management of lung cancer: How to test its efficacy?. J Thorac Oncol 2 1 (2007) 69-72
24. Riedel R.F., Wang X., McCormack M., Toloza E., Montana G.S., Schreiber G., et al. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol 1 (2006) 692-696
25. Kee F., Owen T., and Leathem R. Decision making in a multidisciplinary cancer team: does team discussion result in better quality decisions?. Med Decis Making 24 (2004) 602-613
26. Kee F., Owen T., and Leathem R. Offering a prognosis in lung cancer: when is a team of experts an expert team?. J Epidemiol Community Health 61 (2007) 308-313
27. Fleissig A., Jenkins V., Catt S., and Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK?. Lancet Oncol 7 (2006) 935-943
28. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
29. Campbell N.C., Murray E., Darbyshire J., Emery J., Farmer A., Griffiths F., et al. Designing and evaluating complex interventions to improve health care. BMJ 334 7591 (2007) 455-459
30. Silvestri G.A., Handy J., Lackland D., Corley E., and Reed C.E. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 114 (1998) 675-680
31. Hannan E.L., Radzyner M., Rubin D., Dougherty J., and Brennan M.F. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 131 (2002) 6-15
32. Birkmeyer J.D., Stewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
33. Bach P.B., Cramer L.D., Schrag D., Downey R.J., Gelfand S.E., and Begg C.B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345 (2001) 181-188
34. Lee J.S., Scott C.B., Komaki R., Ettinger D.S., and Sause W.T. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 362-370
35. Romano P.S., and Mark D.H. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 101 (1992) 1332-1337
36. Easterbrook P.J., Berlin J.A., Gopalan R., and Matthews R.D. Publication bias in clinical research. Lancet 337 (1991) 867-872
37. Chan A., Hrobjartsson A., Haahr M.T., Gotzsche P.C., and Altman D.G. Empirical evidence for selective reporting of outcomes in randomized trials. JAMA 291 (2004) 2457-2465
38. Chan A., and Altman D. Identifying outcome reporting bias in randomised trials on Pub Med: review of publications and survey of authors. BMJ 330 (2005) 753-756
39. Houssami N., and Sainsbury R. Breast cancer: multidisciplinary care and clinical outcomes. Eur J Cancer 42 (2006) 2480-2491
40. Wright F., De Vito C., Langer B., and Hunter A. Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer 43 (2007) 1002-1010
41. Davey Smith G., Ebrahim S., and Frankel S. How policy informs the evidence. BMJ 322 (2001) 184-185